United States

People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

9:38am EDT
Change (% chg)

$-0.01 (-0.13%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Panem, Sandra 

Dr. Sandra Panem, Ph.D., is an Independent Director of Acorda Therapeutics, Inc. She is currently a partner at Cross Atlantic Partners, which she joined in 2000. She is also currently President of NeuroNetworks Fund, a not-for-profit venture capital fund focusing on neurodisorders which she co-founded in December 2014. From 1994 to 1999, Dr. Panem was President of Vector Fund Management, the then asset management affiliate of Vector Securities International. Prior thereto, Dr. Panem served as Vice President and Portfolio Manager for the Oppenheimer Global BioTech Fund, a mutual fund that invested in public and private biotechnology companies. Previously, she was Vice President at Salomon Brothers Venture Capital, a fund focused on early and later-stage life sciences and technology investments. Dr. Panem was also a Science and Public Policy Fellow in economic studies at the Brookings Institution, and an Assistant Professor of Pathology at the University of Chicago. She received a B.S. in biochemistry and a Ph.D. in microbiology from the University of Chicago. Dr. Panem currently serves on the boards of directors of Labcyte, Inc. and BioLineRx Ltd. Dr. Panem’s experience investing in life sciences companies, and her long-standing relationship with the Company as a Board representative of one of its earliest investors, provides historical perspective on the Company and the life sciences industry.

Basic Compensation

Total Annual Compensation, USD 74,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 94,500
Fiscal Year Total, USD 168,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen


Richard Batycky


David Lawrence


Jane Wasman


Burkhard Blank


Lauren Sabella

As Of  30 Dec 2017